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Abstract 
Objectives: To assess local histological 
outcomes in patients with HSIL cytology results on 
cervical smears, in both the see-and-treat and three-
step approach. 
Study Design: A retrospective analysis of 
patients with HSIL on cervical cytology was 
performed, obtaining an 83 patient cohort. The 
histological result following the primary 
investigation (colposcopic-directed biopsy or 
excisional procedure) was noted for each patient 
together with their demographic variables and HPV 
status. 
Results: Of 83 patients with HSIL cytology on 
cervical smear, 43 underwent LLETZ as a primary 
procedure, while 40 patients underwent a 
colposcopic-directed biopsy. There was no 
statistically significant difference in terms of 
dermographics and HPV status between the two 
groups. In those patients who had LLETZ as a 
primary procedure, 29 had CIN2+ on histology. On 
the other hand, following colposcopic-directed 
biopsies, 17 resulted in CIN2+ on histology. 
Conclusion: The conventional approach 
within our local setting potentially has inferior 
sensitivity in picking up CIN2+ lesions when 
compared to the see-and-treat approach. On the 
other hand, primary excisional procedures were 
associated with an overtreatment rate of at least 
20.9%, subjecting patients to unnecessary risks. 
Local improvement of colposcopic skill will aid to 
reduce this overtreatment rate and missed lesions at 
biopsy. 
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Introduction 
Cervical carcinoma is the fourth most common 
malignancy in women worldwide, with an 
estimated 4.68 per 100,000 being affected locally 
per year while 9.8 per 100,000 are affected in the 
UK per year.1 Cervical cancer is in the large 
majority of cases preceded by Human Papilloma 
Virus (HPV) infection and pre-malignant changes, 
with HPV 16 and 18 responsible for about 70% of 
all cases. HPV persistence results in the integration 
of viral genetic material into the cellular genome, 
inactivating tumour suppressor function leading to 
genetic instability and precancerous changes.2 
Cervical screening and HPV typing through a 
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Papanicolaou smear or liquid based cytology form 
the basis of cervical cancer screening programmes 
worldwide. 
High-grade squamous intraepithelial lesion 
(HSIL) on cervical cytology is one of the categories 
of the Bethesda classification system used in 
cervical screening programmes. HSIL cytology 
results identify women at substantial risk of cervical 
intraepithelial neoplasia (CIN).3 Women with HSIL 
carry a 7% five-year risk of cervical cancer 
regardless of HPV status.4  
In most screening algorithms, abnormal 
cervical cytology is followed up by 
colposcopically- directed cervical biopsies. If 
CIN2+ is detected on colposcopic biopsies, the 
cervix may be treated by excising the 
transformation zone by using various methods, such 
as a large loop excision of the transformation zone 
(LLETZ). This is referred to as the conventional 
three-step approach.5 
Bigrigg6 initially pioneered the see-and-treat 
protocol for women with abnormal smear results. 
This approach involves assessing the cervix 
macroscopically at colposcopy and directly 
performing a LLETZ procedure should abnormal 
epithelial changes be confirmed. Therefore in this 
approach simultaneous histologic diagnosis and 
treatment is carried out.2 Some 60% of women with 
HSIL on cervical cytology are found to have CIN2+ 
on histology. Thus the American Society for 
Colposcopy and Cervical Pathology (ASCCP) 
recommends immediate excision of the 
transformation zone for non-pregnant females over 
the age of 25, especially if colposcopic examination 
is inadequate. However, primary colposcopy 
including full assessment of the transformation zone 
is also an acceptable approach.3  
Both approaches have their drawbacks. 
Overtreatment is a potential drawback of the ‘see-
and-treat’ approach, whereby patients might 
undergo excisional procedures only to have normal 
or low-grade results on histopathological 
assessment. On the other hand, high-grade CIN may 
be under evaluated in colposcopic-directed biopsies, 
partly due to the subjectivity involved in the 
selection of the site for biopsies.7  
This study aims to assess local histological 
outcomes in patients with HSIL cytology results on 
cervical smears, in both the see-and-treat and three-
step approach. 
Methodology 
This study is a retrospective analysis of an 83 
patient cohort gathered over two years (2015-2017). 
Patients with HSIL on cervical cytology were 
identified through Mater Dei Hospital’s 
histopathological records after the appropriate data 
protection approval was acquired. 
Demographic variables and HPV status, 
including serotypes present, were noted for each 
patient with an HSIL cytological result. The 
histological result following the primary 
investigation in their management plan 
(colposcopic-directed biopsy or excisional 
procedure) were evaluated. 
Results 
Of 83 patients with HSIL cytology on cervical 
smear, 51.8% (n=43) underwent LLETZ as a 
primary procedure, while 48.2% (n =40) patients 
underwent a colposcopic-directed biopsy. Of the 
latter, 14 patients required a LLETZ procedure after 
their first colposcopic-directed biopsy, while 4 
patients underwent a repeat colposcopy, two of 
which ultimately required a LLETZ procedure. The 
remaining 22 patients were followed up with 
cervical cytology (Figure 1). The transformation 
zone was present in 98.8% of cervical biopsies 
taken.  
There were no statistically significant 
differences in mean patient age and HPV positivity 
on statistical analysis of the two main treatment 
arms with a non-paired student t-test. The mean age 
of the LLETZ group was 34.4 years, while the mean 
age of the colposcopic-directed biopsy group was 
35.1 (p=0.5917). The HPV risk profiles were also 
very similar between the two groups (Table 1).  
In those patients who had LLETZ as a primary 
procedure, 67% (n=29) had CIN2+ on histology. 
On the other hand, following colposcopic-directed 
biopsies, 42.5% (n=17) resulted in CIN2+ on 
histology (Figure 2 and Table 2).  Figure 3 shows a 
more detailed breakdown of histological results 
according to the management approach taken. 
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Figure 1: Management pathway for HSIL patients included in the study
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Prevalence of HPV infection and HPV 16/18 serotype infection in the two sub-groups 
 
See-and-treat Approach 
% (95% CI) 
Conventional Approach 
% (95% CI) 
HPV Positivity 76.7 (61.4 - 88.2) 80.0 (64.4 – 90.9) 
HPV 16 or 18 55.8 (39.9 – 70.9) 55.0 (38.5 – 70.7) 
 
 
Figure 2: Histological outcome of the primary procedure performed in the two sub-groups 
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Table 2: Primary histological outcome in two study sub-groups 
Histology See & Treat Approach 
% (95%CI) 
Conventional Approach 
% (95%CI) 
Normal/Cervicitis/Koilocytosis 20.9 (11.40-30.46) 45.0 (30.70-59.30) 
CIN1 11.6 (5.47-17.77) 12.5 (5.46-19.54) 
CIN2+ 67.4 (52.50-82.38) 42.5 (28.50-56.50) 
Figure 3: Detailed breakdown of the histological outcome in the two study sub-groups 
 
 
Discussion 
Papanicolaou’s discovery in the 1940s laid the 
foundation of cervical screening. The aim of 
cervical screening is to identify precancerous 
lesions at an early stage and thus reduce the 
incidence, morbidity and mortality from cervical 
cancer.  Since the implementation of the UK NHS 
Cervical Screening Programme in 1988, the 
incidence of cervical cancer in the UK has 
decreased from 15 per 100,000 in 1986 to 8.9 per 
100,000 in 2012 saving up to 4,500 lives per year.8 
HSIL cytology results identify women at 
substantial risk of CIN2+.  Each year approximately 
1-2% of screened women are diagnosed with
CIN2+, which is found in some 60% of women 
with HSIL.3 This compares well with an overall rate 
of 55.42% of CIN2+ diagnosed in our HSIL patient 
cohort, regardless of the management strategy. 
In this local study a relatively higher incidence 
of CIN2+ pathology was identified in patients who 
underwent a primary excisional procedure as 
opposed to those who had a colposcopic-directed 
biopsy (67% and 42.5% respectively). Since the 
mean age, HPV prevalence and HPV 16 and 18 
prevalence have been shown to be relatively equal 
in both sub-groups, one would expect the 
histological outcomes to be equivalent. Since 
LLETZ is a larger biopsy it enables better 
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histopathological representation of the cervical 
epithelial abnormalities and thus can be considered 
a gold standard in terms of histopathological 
diagnosis sensitivity.5  
The see-and-treat approach is controversial due 
to the possibility of overtreatment. Thus, patients 
might be unnecessarily exposed to risks associated 
with a LLETZ procedure. These include infections, 
bleeding and preterm labour.  The overtreatment 
rate following LLETZ in this study was 20.9%. 
This is referring to those patients with a normal, 
cervicitis or koilocytosis primary histological result. 
If LLETZ for CIN1 is also regarded as 
overtreatment, this figure increases to 32.5%. The 
overtreatment rate varies widely in different studies, 
but has been reported to be between 13.3-83.3% for 
LLETZ performed following HSIL cytology. The 
large majority of these studies do include CIN1 
histologies when defining overtreatment, since 
CIN1 has a relatively high spontaneous regression 
rate.7  
Excisional procedures carry a higher rate of 
complications than biopsies, both short-term and 
long-term. Short-term complications, though 
usually minor, include bleeding, pelvic pain, and 
infection. There is also conflicting evidence 
associating LLETZ procedures with a higher risk of 
preterm delivery in future pregnancies. Nonetheless, 
the see-and-treat strategy is the primary mode of 
treatment in several centres due to lower costs, 
decreased patient anxiety, and increased compliance 
making it appealing for patients at risk of being lost 
to follow-up.9, 10 Nevertheless there has never been 
a local study assessing compliance to treatment and 
outpatient clinical follow-up. This would be of 
value, since the issue of non-compliance may not 
play a significant role in a small country with one 
state hospital.  
Histological diagnosis from definitive 
treatment, such as excisional procedures, as already 
discussed, sometimes identify a more advanced 
stage of CIN than do colposcopic biopsies, where 
the severity of the cervical lesion may be 
underestimated.11 Although cervical biopsies should 
represent the worst epithelial changes present on the 
cervix, this is not always the case in view of the 
subjective nature of colposcopic examination and 
possibly suboptimal colposcopic technique.  
In a prospective study by Buxton EJ et al of 
243 women, there was a higher rate of detection of 
severe lesions obtained following excisional 
procedures versus colposcopically-directed 
biopsies; a difference of 25.5%.12 Similarly in this 
study, a 24.9% discrepancy in CIN2+ detection was 
noted between the conventional approach and the 
see-and-treat approach, with the highest pick up rate 
obtained with primary excisional procedures. This 
potentially represents an underestimation of CIN, 
which can have potentially serious implications on 
patient outcome since it could lead to false 
reassurance for both clinician and patient.  
Moreover, inter-observer variation in 
interpretation of colposcopic images exists, 
resulting in unfavourable colposcopic biopsies. 
There is also significant potential error due to the 
subjective nature of the examination as reflected in 
selection of the site for biopsy. In a prospective 
study by Pretorius RG et al in 2004, a comparison 
was made between histological results obtained 
from colposcopically- directed biopsies versus 
cervical biopsies taken at random without the guide 
of a colposcope.   It was reported that 57.1% of 
colposcopy-directed biopsies were CIN2+ while 
only 37.4% of random biopsies showed this same 
histology result.13 This implies that colposcopic 
skill has a significant effect on diagnosis and patient 
management. CIN2+ rates in our local study fall 
just above the rate of random biopsies described in 
the latter study. One could thus hypothesise that 
local colposcopic expertise could be limiting the 
accurate diagnosis of CIN2+ in HSIL patients.  
With the mean age of the two patient cohorts 
being relatively equal, differences in outcome 
variables could be more reliably linked to respective 
mode of management.  One would expect a 
discrepancy in the mean ages as women below the 
age of 24 years are advised to undergo a colposcopy 
first, while for women over 24 years a colposcopy 
or a primary excisional procedure may be 
considered. This is due to the higher rates of 
regression in women under 24 years of age and 
risks of preterm labour following surgical cervical 
trauma.12 This could be due to a large proportion of 
older patients being channelled through the more 
conservative interval approach despite their age.  
 
Conclusion 
Local management of patients with HSIL 
cytology remains controversial. Our results have 
shown that the conventional approach within our 
local setting potentially has inferior sensitivity in 
picking up CIN2+ lesions when compared to the 
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see-and-treat approach, with a discrepancy of 
24.9%. This possibly represents a proportion of 
false negative results which could carry 
implications on patient outcome. On the other hand, 
primary excisional procedures were associated with 
an overtreatment rate of at least 20.9%, potentially 
subjecting patients to unnecessary risks. 
Certainly, our local colposcopic service would 
benefit from improved colposcopic expertise, with 
the aim of improving the sensitivity of colposcopic-
directed biopsies. Furthermore, the basis of the see-
and-treat approach involves primarily assessing the 
cervix macroscopically via colposcopy, and only 
proceeding to a LLETZ if the colposcopic 
impression is suggestive of high-grade findings. 
Thus by improving the skill and confidence of the 
colposcopist, patients with HSIL who are found to 
have a macroscopically healthy cervix could be 
shifted to the three-step approach. In this way, the 
rate of overtreatment would be expected to 
decrease. 
In conclusion, we recommend improving local 
colposcopic skill in order to reduce the rate of 
overtreatment and missed lesions at biopsy. This 
could be achieved by having these procedures 
performed by experienced and accredited 
colposcopists, as well as by setting up a structured 
colposcopy training programme for specialty 
trainees. This study could be repeated in the future 
once the necessary improvements to our 
colposcopic service have been enacted.   
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